Compounds > thalidomide

Page last updated: 2024-08-16

thalidomide and o-(chloroacetylcarbamoyl)fumagillol

thalidomide has been researched along with o-(chloroacetylcarbamoyl)fumagillol in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (40.00)	18.2507
2000's	5 (50.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Ziegler, J	1
Kuwano, M; Ono, M	2
Yarchoan, R	1
Libutti, SK; Zogakis, TG	1
Herbst, RS; Kim, ES	1
Dallabrida, SM; Folkman, MJ; Langer, R; Lowell, BB; Panigrahy, D; Rupnick, MA; Zhang, CY	1
Ponzoni, M; Ribatti, D	1
Bielenberg, DR; D'Amore, PA	1

Reviews

7 review(s) available for thalidomide and o-(chloroacetylcarbamoyl)fumagillol

Article	Year
[Development of anti tumor agents targeting angiogenesis]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:2 Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclohexanes; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hydroxamic Acids; Interferon-alpha; Interleukin-12; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phenylalanine; Platelet Factor 4; Polysaccharides, Bacterial; Sesquiterpenes; Thalidomide; Thiophenes; Triazines; Triazoles; Tumor Cells, Cultured	1997
[Neovascularization and tumor development]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Aug-10, Volume: 87, Issue:8 Topics: Angiostatins; Antibiotics, Antineoplastic; Antineoplastic Agents; Collagen; Cyclohexanes; Endostatins; Humans; Hydroxamic Acids; Interferons; Interleukin-12; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Phenylalanine; Plasminogen; Sesquiterpenes; Thalidomide; Thiophenes	1998
Therapy for Kaposi's sarcoma: recent advances and experimental approaches. Journal of acquired immune deficiency syndromes (1999), 1999, Aug-01, Volume: 21 Suppl 1 Topics: Administration, Oral; Alitretinoin; Anthracyclines; Antineoplastic Agents; Cyclohexanes; Humans; Immunosuppressive Agents; Liposomes; Neoplasms; O-(Chloroacetylcarbamoyl)fumagillol; Paclitaxel; Sarcoma, Kaposi; Sesquiterpenes; Thalidomide; Tretinoin	1999
General aspects of anti-angiogenesis and cancer therapy. Expert opinion on biological therapy, 2001, Volume: 1, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Antibodies; Clinical Trials as Topic; Collagen; Cyclohexanes; Endostatins; Endothelial Growth Factors; Fatty Acids, Unsaturated; Humans; Interleukin-12; Lymphokines; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasms; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Receptors, Vitronectin; RNA, Catalytic; Sesquiterpenes; Suramin; Thalidomide; Triazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2001
Angiogenesis inhibitors in lung cancer. Current oncology reports, 2002, Volume: 4, Issue:4 Topics: Angiogenesis Inhibitors; Angiostatins; Carcinoma, Non-Small-Cell Lung; Collagen; Cyclohexanes; Endostatins; Humans; Lung Neoplasms; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Plasminogen; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Sesquiterpenes; Survival Rate; Thalidomide	2002
Antiangiogenic strategies in neuroblastoma. Cancer treatment reviews, 2005, Volume: 31, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cyclohexanes; Disease Progression; Endostatins; Humans; Liposomes; Neovascularization, Pathologic; Neuroblastoma; O-(Chloroacetylcarbamoyl)fumagillol; Prognosis; Receptor, trkA; Retinoids; Sesquiterpenes; Thalidomide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2005
Judah Folkman's contribution to the inhibition of angiogenesis. Lymphatic research and biology, 2008, Volume: 6, Issue:3-4 Topics: Allergy and Immunology; Angiogenesis Inhibitors; Animals; Cyclohexanes; History, 20th Century; History, 21st Century; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medical Oncology; Models, Biological; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Sesquiterpenes; Thalidomide	2008

Other Studies

3 other study(ies) available for thalidomide and o-(chloroacetylcarbamoyl)fumagillol

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Angiogenesis research enjoys growth spurt in the 1990s. Journal of the National Cancer Institute, 1996, Jun-19, Volume: 88, Issue:12 Topics: Antineoplastic Agents; Cyclohexanes; Drugs, Investigational; Endothelial Growth Factors; Humans; Interferon-alpha; Lymphokines; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Polysaccharides, Bacterial; Sesquiterpenes; Thalidomide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1996
Adipose tissue mass can be regulated through the vasculature. Proceedings of the National Academy of Sciences of the United States of America, 2002, Aug-06, Volume: 99, Issue:16 Topics: Adipose Tissue; Angiogenesis Inhibitors; Angiostatins; Animals; Antineoplastic Agents; Biphenyl Compounds; Body Composition; Body Weight; Collagen; Cyclohexanes; Disease Models, Animal; Endostatins; Energy Metabolism; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Obesity; Organic Chemicals; Peptide Fragments; Phenylbutyrates; Plasminogen; Sesquiterpenes; Thalidomide; Time Factors	2002